Hosted on MSN17h
Taking This Vitamin Could Protect You From Parkinson's Disease, New Research Shows
Y es, Parkinson's is a disease that effects nerve cells in the brain, leading to tremors, stiffness, speech changes and more, ...
70 countries have banned this pesticide. It’s still for sale in the U.S.
Paraquat has drawn scrutiny for its possible links to Parkinson’s disease. It’s one of the most widely used pesticides in the ...
Wireless Nanoparticle-Based System Found To Reverse Parkinson’s Disease
A novel wireless photothermal DBS nanosystem uses nanoparticles to target and restore damaged neurons in Parkinson’s disease, ...
Laredo Morning Times on MSN12h
Laredo Parkinson’s Support Group to host expert speaker on sleep, Parkinson’s
Laredo Parkinson’s Support Group will host UT Health San Antonio’s Dr. Eleni Vaou speaking on sleep and Parkinson’s at its ...
IRLAB Therapeutics: IRLAB has Received a Waiver from the EMA Regarding Pediatric Studies with Mesdopetam in Parkinson's Disease
GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...
Newcastle hospital one of just four in the world to use brain implant to treat Parkinson's
Consultant neurosurgeon Akbar Hussain' s passion for the technology has helped Newcastle to be at the forefront of its ...
Simple tweak to your morning routine could help reduce your Parkinson's risk
A health expert has claimed that just one simple change to your morning routine could help to reduce your risk of developing ...
University of Liverpool20h
Revealing insights into neurological disease treatment
Scientists from the University of Liverpool, and their global collaborators have highlighted the most effective treatments ...
Paper Explores Utility of Biomarker Testing in Early Diagnosis and Treatment of Synucleinopathies
New biomarker tests can enable early diagnosis and prompt treatment of symptoms associated with synucleinopathies, according ...
Zydus Life rises after USFDA grants orphan drug status to Usnoflast for ALS treatment
Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...
MeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder Value
MeiraGTx's financials show $125 million in cash, but additional funding will be needed within the next 12 months. Click for ...